Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-011143
Filing Date
2025-02-11
Accepted
2025-02-11 06:52:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10456
  Complete submission text file 0001104659-25-011143.txt   12139
Mailing Address SUITE 2606, TOWER I NEW RICHPORT CENTER, 763 MENGZI ROAD SHANGHAI F4 200023
Business Address SUITE 2606, TOWER I NEW RICHPORT CENTER, 763 MENGZI ROAD SHANGHAI F4 200023 86 (21) 6315 1313
BVCF IV, L.P. (Filed by) CIK: 0001761158 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SCHEDULE 13G/A

Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94014 | Film No.: 25607635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)